[HTML] nature.comFull View

[HTML][HTML] Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li, G Li… - Nature …, 2017 - nature.com
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …
被引用次数：95 相关文章

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li, G Li… - Nature …, 2017 - hero.epa.gov
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li, G Li… - Nature …, 2017 - ideas.repec.org
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li… - Nature …, 2017 - econpapers.repec.org
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells.

J Cui, L Qin, J Zhang, P Abrahimi, H Li… - Nature …, 2017 - search.ebscohost.com
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li… - Nature …, 2017 - ui.adsabs.harvard.edu
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li, G Li… - Nature …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Human endothelial cells are initiators and
targets of the rejection response. Pre-operative modification of endothelial cells by small …
[HTML] nih.gov

[HTML][HTML] Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

J Cui, L Qin, J Zhang, P Abrahimi, H Li, G Li… - Nature …, 2017 - ncbi.nlm.nih.gov
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells.

J Cui, L Qin, J Zhang, P Abrahimi, H Li, G Li… - Nature …, 2017 - europepmc.org
Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …